Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04788030
Other study ID # 650/2018BO2-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2008
Est. completion date January 31, 2021

Study information

Verified date March 2021
Source BG Trauma Center Tuebingen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Muscle-in-vein conduits (MVCs) provide an alternative for bridging digital nerve defects when tension-free suture is not possible. Low donor site morbidity and absence of additional costs are favorable advantages compared to autografts or conduits. 37 patients with 43 defects of proper palmar digital nerves were retrospectively enrolled. Primary repair by MVCs was performed in 22 cases while 21 underwent secondary reconstruction. Recovery of sensibility was assessed by static and moving two-point discrimination (2PDs, 2PDm) and Semmes-Weinstein monofilaments (SWM). Results were compared with contralateral side serving as intraindividual control. Outcome data were stratified according to international guidelines and evaluated for differences in terms of age, gap length, time of reconstruction and concomitant injuries.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date January 31, 2021
Est. primary completion date December 31, 2017
Accepts healthy volunteers No
Gender All
Age group 6 Years to 72 Years
Eligibility Inclusion Criteria: - Patients with reconstruction of digital nerves with muscle-in-vein conduits Exclusion Criteria: - Subtotal or total amputations - pre-existing neurological disorders (e.g. polyneuropathy) - symptoms of nerve entrapment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nerve reconstruction
Nerve bridging with muscle-in-vein conduits

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
BG Trauma Center Tuebingen

Outcome

Type Measure Description Time frame Safety issue
Primary Two-point discrimination Six months after reconstruction or later
Primary Semmes-Weinstein-Monofilament test Six months after reconstruction or later
Secondary Age Baseline
Secondary Gap length Baseline
Secondary Time of reconstruction Baseline
Secondary Concomitant injuries Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05160038 - Embodied Virtual Reality for Chronic Pain N/A
Recruiting NCT05884125 - Promoting Healing of Injured Nerves With Electrical Stimulation Therapy N/A
Recruiting NCT05207878 - Interhemispheric Connectivity and Compensation N/A
Active, not recruiting NCT03964129 - BMAC Nerve Allograft Study N/A